Adipose derived Stem Cell

Developed for: ischemic disease · peripheral vascular disease · rotator cuff syndrome · stroke disorder
Investigated by: Academy Military Medical Science, China · Andaluz Health Service · Assistance Publique - Hôpitaux de Paris · Association Groupe ESSEC · CH Sainte-Anne, Paris, France · Centre Hospitalier Universitaire de Besancon
+30 more
· Etablissement Français du Sang · Finovatis · French National Institute of Health and Medical Research · Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León · Histocell SL, Spain · Horizon 2020 - European Commission · Hospices Civils de Lyon · Hospital Vall d'Hebron · Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · Jie Shen · NOVADISCOVERY SAS, France · Nanfang Hospital, Southern Medical University · Oy Medfiles Ltd · Pirkanmaa Hospital District, Tampere, Finland · Sant Pau Research Institute · Servicio Gallego de Salud · Servicio Madrileño de Salud, Madrid, Spain · Servicio de Salud de Castilla La Mancha, Albacete, Spain · Southern Medical University, China · St. Anne's University Hospital Brno, Czech Republic · Tampere University · The Fifth Affiliated Hospital of Southern Medical University · University Grenoble Alps · University Hospital, Bordeaux · University Hospital, Caen · University Hospital, Grenoble · University Hospital, Toulouse · University of Eastern Finland · University of Glasgow · University of Southern Denmark

201520162017201820192020202120222023202420252026202720282029

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 12 trials
Phase 1	NCT03570450	Jun 2018 → Jul 2025 overdue	stroke disorder	University Hospital, Grenoble	Recruiting	No outcome recorded
Phase 1	NCT02831075	Jan 2015 → Dec 2017	ischemic disease, peripheral vascular disease	Jie Shen	Unknown	No outcome recorded
Phase 1/21 trial
Phase 1/2	NCT07592936	Aug 2026 → Aug 2028 expected	rotator cuff syndrome	University of Southern Denmark	Not yet recruiting	No outcome recorded

Every value below carries the sentence it was read from. 4 sources stand behind the page.

Field	Value	Cited text
Known as	Adipose derived Stem Cell	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03570450 ↗ 2 NCT02831075 ↗ NCT07592936 ↗
Modality	Cell therapy	“Stem cell therapy” NCT02831075 ↗
Route	Intravenous	“intravenous (IV) infusion” PMID 41542240 ↗ Sep 2024